AMARIN CORP PLC\UK Insider Trading for September 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMARIN CORP PLC\UK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMARIN CORP PLC\UK for September 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Option Exercise | M | 3.40 | 500,000 | 1,700,000 | 1,050,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 12.18 | 65,800 | 801,319 | 226,047 | 291.8 K to 226 K (-22.55 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 11.23 | 26,949 | 302,678 | 291,847 | 318.8 K to 291.8 K (-8.45 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Sell | S | 10.30 | 407,251 | 4,195,337 | 318,796 | 726 K to 318.8 K (-56.09 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Zakrzewski Joseph S | Director | Buy | M | 3.40 | 500,000 | 1,700,000 | 726,047 | 226 K to 726 K (+221.19 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 8.77 | 200,000 | 1,754,000 | 300,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 8.77 | 100,000 | 877,000 | 500,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 8.10 | 33,750 | 273,375 | 0 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.95 | 52,147 | 153,834 | 80,853 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 142,500 | 356,250 | 37,500 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 112,500 | 281,250 | 67,500 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 2.50 | 158,334 | 395,835 | 41,666 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Option Exercise | M | 1.40 | 20,834 | 29,168 | 44,270 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 14.00 | 100,000 | 1,400,000 | 341,297 | 441.3 K to 341.3 K (-22.66 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 13.00 | 100,000 | 1,300,000 | 441,297 | 541.3 K to 441.3 K (-18.47 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 8.77 | 200,000 | 1,754,000 | 541,297 | 341.3 K to 541.3 K (+58.60 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 12.00 | 100,000 | 1,200,000 | 341,297 | 441.3 K to 341.3 K (-22.66 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 10.94 | 49,450 | 540,869 | 441,297 | 490.7 K to 441.3 K (-10.08 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Sell | S | 10.04 | 529,791 | 5,319,155 | 490,747 | 1 M to 490.7 K (-51.91 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 8.77 | 100,000 | 877,000 | 1,020,538 | 920.5 K to 1 M (+10.86 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 8.10 | 33,750 | 273,375 | 920,538 | 886.8 K to 920.5 K (+3.81 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.95 | 52,147 | 153,834 | 886,788 | 834.6 K to 886.8 K (+6.25 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 142,500 | 356,250 | 834,641 | 692.1 K to 834.6 K (+20.59 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 112,500 | 281,250 | 692,141 | 579.6 K to 692.1 K (+19.41 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 2.50 | 158,334 | 395,835 | 579,641 | 421.3 K to 579.6 K (+37.58 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Buy | M | 1.40 | 20,834 | 29,168 | 421,307 | 400.5 K to 421.3 K (+5.20 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 1.40 | 80,730 | 113,022 | 44,270 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 2.50 | 712,491 | 1,781,228 | 187,509 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 1.02 | 83,985 | 85,665 | 9,765 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Option Exercise | M | 2.04 | 202,500 | 413,100 | 0 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 12.14 | 139,706 | 1,695,696 | 217,934 | 357.6 K to 217.9 K (-39.06 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 11.14 | 55,200 | 615,110 | 357,640 | 412.8 K to 357.6 K (-13.37 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Sell | S | 10.27 | 884,800 | 9,090,170 | 412,840 | 1.3 M to 412.8 K (-68.19 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 1.40 | 80,730 | 113,022 | 1,297,640 | 1.2 M to 1.3 M (+6.63 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 2.50 | 712,491 | 1,781,228 | 1,216,910 | 504.4 K to 1.2 M (+141.25 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 1.02 | 83,985 | 85,665 | 504,419 | 420.4 K to 504.4 K (+19.98 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Buy | M | 2.04 | 202,500 | 413,100 | 420,434 | 217.9 K to 420.4 K (+92.92 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Option Exercise | M | 2.19 | 150,000 | 328,500 | 475,000 | |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Sell | S | 10.72 | 70,200 | 752,621 | 14,996 | 85.2 K to 15 K (-82.40 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Sell | S | 10.15 | 79,800 | 810,130 | 85,196 | 165 K to 85.2 K (-48.36 %) |
| Sep 26 2018 | AMRN | AMARIN CORP PLC\UK | Kalb Michael Wayne | SVP and CFO | Buy | M | 2.19 | 150,000 | 328,500 | 164,996 | 15 K to 165 K (+1,000.27 %) |
| Sep 25 2018 | AMRN | AMARIN CORP PLC\UK | Kennedy Joseph T | General Counsel | Grant | A | 0.00 | 199,500 | 0 | 217,934 | 18.4 K to 217.9 K (+1,082.24 %) |
| Sep 25 2018 | AMRN | AMARIN CORP PLC\UK | Ketchum Steven B | Chief Scientific Of ... | Grant | A | 0.00 | 199,500 | 0 | 400,473 | 201 K to 400.5 K (+99.27 %) |
| Sep 25 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Payment of Exercise | F | 2.99 | 497,876 | 1,488,649 | 2,271,785 | 2.8 M to 2.3 M (-17.98 %) |
| Sep 25 2018 | AMRN | AMARIN CORP PLC\UK | THERO JOHN F | President and CEO | Grant | A | 0.00 | 1,265,250 | 0 | 2,769,661 | 1.5 M to 2.8 M (+84.10 %) |